CoChat

Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?

Open access
Tarantino, Giovanni, Conca, Paolo, Riccio, Antonio, Tarantino, Marianna, Di Minno, Matteo N, Chianese, Domenico, Pasanisi, Fabrizio, Contaldo, Franco, Scopacasa, Francesco, Capone, Domenico · 2008 · Journal of Translational Medicine
Cited by 83

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Inside the spectrum of non-alcoholic fatty liver disease, simple fatty liver is generally thought of as being "non progressive", differently from non-alcoholic steatohepatitis, which increases in severity due to the presence of apoptosis/inflammation and fibrosis. The "benignity" of fatty liver is widely accepted but conceptually difficult to maintain because the mechanisms underlying this entity are the same ones that determine the more severe form.Findings provide evidence that iron overload is associated with increased liver damage and collagen deposition. Transforming growth factor-beta1 released by hepatic stellate cells during chronic liver injury plays a critical role in liver apoptosis and fibrogenesis. OBJECTIVE: To verify whether both the forms of non-alcoholic fatty liver disease were really dissimilar, evaluating the serum profile of two key parameters, indexes of severity. METHODS: A total of 123 patients (57 females) participated, forming three groups: forty five patients with fatty liver, 42 patients with non-alcoholic steatohepatitis and 36 with chronic hepatitis C. All had a biopsy-proven diagnosis. MEASUREMENTS: Serum concentrations of transforming growth factor-beta1 and ferritin. RESULTS: High concentrations of transforming growth factor-beta1 were noticed in patients suffering from both fatty liver and non-alcoholic steatohepatitis, 129.1 (45.4) versus 116.8 (42.2) ng/mL, P = 0.2; they were significantly superior to those of chronic hepatitis C patients 87.5 (39.5) ng/mL, P < 0.001. Ferritin levels were on average above normal values and similar in the three groups (P = 0.9), also when adjusted for gender (P = 0.5) and age (P = 0.3). CONCLUSION: No difference between serum concentrations of transforming growth factor-beta1 and ferritin in fatty liver and non-alcoholic steatohepatitis suggests that these forms share more common aspects, regarding their progression, than previously thought.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1479-5876-6-72

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 83

Metadata

Authors
Tarantino, G., Conca, P., Riccio, A., Tarantino, M., Di Minno, M. N., Chianese, D., Pasanisi, F., Contaldo, F., Scopacasa, F., & Capone, D.
Venue
Journal of Translational Medicine
Published
2008-11-27
Volume
6
Issue
1
Pages
72-72
ISSN
1479-5876 (ISSN-L)
OpenAlex
W2111696876
Cited by
83
References
4
FWCI
3.50
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign? https://app.cochat.ai/papers/10.1186/1479-5876-6-72
The paper
Tarantino, G., Conca, P., Riccio, A., Tarantino, M., Di Minno, M. N., Chianese, D., Pasanisi, F., Contaldo, F., Scopacasa, F., & Capone, D. (2008). Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign? Journal of Translational Medicine. https://doi.org/10.1186/1479-5876-6-72

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.